Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.

doi:10.1002/ajh.25946

Article

Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.

American journal of hematology - 1 Nov 2020

Russo Roberta, Marra Roberta, Andolfo Immacolata, Manna Francesco, De Rosa Gianluca, Rosato Barbara Eleni, Radhakrishnan Kottayam, Fahey Michael, Iolascon Achille

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.

Abstract excerpt

Topics

Related research